Mid-term report 2013 - The European LeukemiaNet
Mid-term report 2013 - The European LeukemiaNet
Mid-term report 2013 - The European LeukemiaNet
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>European</strong> <strong>LeukemiaNet</strong> <strong>Mid</strong><strong>term</strong> Report, 08-RNP-071<br />
7.3.2. Lectures<br />
Date City Title of the congress or symposia Title of the lecture Speaker<br />
09.04.2010 Kiew<br />
Workshop " Modern diagnostic and treatment<br />
approach to chronic myeloid leukemia"<br />
On the path to cure CML - New developments<br />
Prof. R. Hehlmann, ELN Coordinator<br />
09.04.2010 Kiew<br />
Workshop "Modern diagnostic and treatment Should first line imatinib treatment be optimized by combination<br />
Prof. R. Hehlmann, ELN Coordinator<br />
approach to CML"<br />
with IFN or by higher imatinib dose?<br />
12.04.2010 Genova International Meeting on CML Updated ELN recommendations for the management of CML Prof. R. Hehlmann, ELN Coordinator<br />
18.04.2010 Washington<br />
AACR - session on coordination of translational <strong>European</strong> <strong>LeukemiaNet</strong>,<br />
cancer research at the EU<br />
enabling personalized Leukemia diagnosis in Europe and beyond<br />
Prof. R. Hehlmann, ELN Coordinator<br />
24.04.2010 Warsaw Polish School of Hematology First and second line therapy of CML Prof. R. Hehlmann, ELN Coordinator<br />
08.05.2010 Split<br />
CML Symposium at Croatian Cooperative Group for <strong>European</strong> cooperation in leukemia research. Challenges and<br />
Heamtologycal disorders<br />
perspectives<br />
Prof. R. Hehlmann, ELN Coordinator<br />
17.05.2010 Naples <strong>European</strong> fellows educational day<br />
EUTOS for CML. An innovative collaboration between ELN and<br />
Novartis<br />
Prof. R. Hehlmann, ELN Coordinator<br />
17.05.2010 Naples<br />
<strong>The</strong> management of CML: current treatment<br />
Stem cell transplantation in CML treatment, and accelerated and<br />
paradigms and future perspectives. An educational<br />
blast phase management<br />
day for <strong>European</strong> fellows<br />
Dr. Susanne Saußele<br />
18.05.2010 Naples <strong>European</strong> fellows educational day <strong>The</strong> revised ELN recommendations Prof. R. Hehlmann, ELN Coordinator<br />
04.06.2010 Chicago ASCO<br />
Current best practices for management of accelerated / blast<br />
phase CML<br />
Prof. R. Hehlmann, ELN Coordinator<br />
01.10.2010 Venice Viruses, Genes and Cancer workshop Viral expression and pathogenesis Prof. R. Hehlmann, ELN Coordinator<br />
13.10.2010 Brussels<br />
<strong>European</strong> Cancer Patient Coalition (ECPC) Cancer <strong>The</strong> <strong>European</strong> <strong>LeukemiaNet</strong> Cooperative research to cure<br />
Summit: Making the Cancer Partnership work leukemia<br />
Prof. R. Hehlmann, ELN Coordinator<br />
20.10.2010 Vienna<br />
ELN Frontiers Meeting 2010 ‘New benchmarks in<br />
leukemia: Focus on CML, AML and MDS’<br />
Improving CML Management and the path to cure<br />
Prof. R. Hehlmann, ELN Coordinator<br />
23.10.2010 Vienna<br />
ELN Frontiers Meeting 2010 ‘New benchmarks in<br />
leukemia: Focus on CML, AML and MDS’<br />
<strong>The</strong> concept of cure and the path to cure<br />
Prof. R. Hehlmann, ELN Coordinator<br />
28.10.2010 Sinaia Society of Hematology, Romania<br />
Current options for first line treatment of CML and impact on<br />
prognosis<br />
Prof. R. Hehlmann, ELN Coordinator<br />
04.12.2010 Orlando CML Workshop How to optimize TKI treatment Dose? Schedule? Interferon? Prof. R. Hehlmann, ELN Coordinator<br />
07.12.2010 Mission Inn Fifth International Workshop in CML and MPN<br />
Treatment optimization in CML by tolerability adapted high dose<br />
imatinib<br />
Prof. R. Hehlmann, ELN Coordinator<br />
20.01.2011 Bologna<br />
Nuovi Traguardi nella Cura della Leucemia Mieloide<br />
Chronic myeloid leukemia - Once upon a time<br />
Cronica<br />
Prof. R. Hehlmann, ELN Coordinator<br />
26.03.2011 Warsaw Polish School of Hematology New first line approaches to a cure of CML Prof. R. Hehlmann, ELN Coordinator<br />
31.03.2011 Brüssel Hearing zur Clinical trial directive Clinical trials directive Prof. R. Hehlmann, ELN Coordinator<br />
03.05.2011 Wiesbaden<br />
117. Kongress der Deutschen Gesellschaft für<br />
Innere Medizin e.V.<br />
Neues in der <strong>The</strong>rapie der chronischen myeloischen Leukämien Dr. S. Saußele<br />
16.05.2011 Neapel <strong>European</strong> fellows educational day How to manage blast crisis Dr. Susanne Saußele<br />
16.05.2011 Neapel <strong>European</strong> fellows educational day<br />
Management of special CML populations: pregnant, paedriatric<br />
and elderly patients<br />
Dr. Susanne Saußele<br />
17.05.2011 Naples <strong>European</strong> fellows educational day Successes and perspectives of treatment optimization Prof. R. Hehlmann, ELN Coordinator<br />
17.05.2011 Naples <strong>European</strong> fellows educational day<br />
EUTOS for CML - the collaboration between ELN and Novartis<br />
continues<br />
Prof. R. Hehlmann, ELN Coordinator<br />
17.05.2011 Naples <strong>European</strong> fellows educational day<br />
Advanced methods and clinical application of disease monitoring:<br />
Prof. Dr. Martin Müller<br />
BCR-ABL quantification and mutation detection<br />
20.05.2011 St. Petersburg Symposium <strong>The</strong> goals of CML therapy Prof. R. Hehlmann, ELN Coordinator<br />
02.07.2011 Mannheim EUTOS-Meeting EURO-SKI Dr. S. Saußele<br />
02.07.2011 Mannheim EUTOS-Meeting Variant chromosomal aberrations Dr. S. Saußele<br />
09.09.2011 Berlin<br />
1st International Congress on Controversies in<br />
Stem Cell and Cellular <strong>The</strong>rapies (COSTEM)<br />
Allogenic SCT for CML<br />
Prof. R. Hehlmann, ELN Coordinator<br />
10.09.2011 Bonn<br />
Fortbildungsveranstaltung: Fortschritte in der<br />
<strong>The</strong>rapie Hämatologischer Neoplasien,<br />
Erstlinientherapie der CML<br />
Prof. R. Hehlmann, ELN Coordinator<br />
Universitätsklinikum Bonn<br />
12.09.2011 Kurashiki Invited speech at the University Approaching cure in chronic myeloid Leukemia Prof. R. Hehlmann, ELN Coordinator<br />
13.09.2011 Fukuoka Invited speech at the University New standards of care in CML Prof. R. Hehlmann, ELN Coordinator<br />
14.09.2011 Tsukuba Invited speech at the University Approaching cure in chronic myeloid Leukemia Prof. R. Hehlmann, ELN Coordinator<br />
15.09.2011 Tokyo XXV. Symposia of the IACRLRD Prognostic factors in CML Dr. S. Saußele<br />
16.09.2011 Tokyo<br />
XXV. Symposia of the IACRLRD, 50 years Jubilee<br />
lecture<br />
Approaching a cure in chronic myeloid Leukemia<br />
Prof. R. Hehlmann, ELN Coordinator<br />
19.09.2011 Dubrovnik<br />
“LEUKEMIA AND LYMPHOMA - East and West Are<br />
Together”<br />
Prognostic tools in CML<br />
Prof. R. Hehlmann, ELN Coordinator<br />
28.09.2011 Kiew Workshop "Perspectives of frontline <strong>The</strong>rapy" First-line treatment options for CML in 2011 Prof. R. Hehlmann, ELN Coordinator<br />
08.10.2011 Berlin ELN Frontiers Meeting Imatinib optimisation strategies – can we improve outcomes? Prof. R. Hehlmann, ELN Coordinator<br />
08.10.2011 Berlin ELN Frontiers Meeting Quality of life of patients with CML Dr. S. Saußele<br />
09.10.2011 Berlin ELN Frontiers Meeting New treatment approaches aiming at cure Prof. R. Hehlmann, ELN Coordinator<br />
14.10.2011 Bergamo<br />
Independent Clinical Research in Oncology, Revision of the Clinical Trials Directive 2001 – challenges and<br />
Fondazione Internazionale Menarini<br />
chances<br />
Prof. R. Hehlmann, ELN Coordinator<br />
14.10.2011 Bergamo<br />
Independent Clinical Research in Oncology,<br />
Fondazione Internazionale Menarini<br />
Chronic myeloid leukemia<br />
Prof. R. Hehlmann, ELN Coordinator<br />
20
Change language